← SynDRA
VECABRUTINIB
SynDRA canonical compound SYN0039730 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | BTK | ITK |
|---|
| Mechanism of action | Bruton's tyrosine kinase (BTK) inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- BTK INHIBITOR
- Tyrosine-protein kinase BTK inhibitor
- Bruton's tyrosine kinase (BTK) inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- SNS-062
- BIIB-062
- BSK-4841
- FP-0182
- FP0182
- UNII-PQ7O0OB5GU
- PQ7O0OB5GU
- Vecabrutinib [INN]
- SCHEMBL16765727
- FP-182
- SNS 062
- SNS062
- BIIB062
- vecabrutinibum
- RefChem:933957
- Vecabrutinib [USAN]
- Vecabrutinib [USAN:INN]
- MFCD31692359
- Vecabrutinib (USAN/INN)
- C22H24ClF4N7O2
- VECABRUTINIB [WHO-DD]
- orb1706486
- SCHEMBL29368866
- GTPL10231
- QLRRJMOBVVGXEJ-XHSDSOJGSA-N
- GLXC-21844
- EX-A3159
- KKC82906
- BDBM50546200
- NSC810114
- WHO 10643
- ZB1596
- AKOS040742809
- NSC-810114
- NCGC00689087-01
- AC-36339
- DA-78850
- MS-29801
- HY-109078
Look up VECABRUTINIB in the interactive SynDRA portal →